Wojcikiewicz Richard J H
Department of Pharmacology, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210-2339, USA.
Trends Pharmacol Sci. 2004 Jan;25(1):35-41. doi: 10.1016/j.tips.2003.11.008.
The transmission of information through G-protein-coupled receptor (GPCR)-initiated signaling pathways is modulated in several ways. Although phosphorylation of some of the proteins that populate these pathways is a well-known modulatory process, recent studies have shown that signaling proteins can also undergo regulated ubiquitination in response to GPCR activation, with diverse consequences. To date, three GPCRs, some of their associated proteins and certain downstream mediators, notably inositol (1,4,5)-trisphosphate [Ins(1,4,5)P(3)] receptors, have been shown to be ubiquitinated following GPCR activation. Regulated ubiquitination causes proteasomal degradation of Ins(1,4,5)P(3) receptors and appears to control GPCR endocytosis and trafficking. Defining the roles of ubiquitination in GPCR-mediated signaling is an important task because novel drugs that perturb the ubiquitin-proteasome pathway are now being approved as therapeutic agents.
通过G蛋白偶联受体(GPCR)启动的信号通路进行的信息传递受到多种方式的调节。尽管构成这些通路的一些蛋白质的磷酸化是一个众所周知的调节过程,但最近的研究表明,信号蛋白也可响应GPCR激活而发生受调控的泛素化,产生多种后果。迄今为止,已有三种GPCR、它们的一些相关蛋白以及某些下游介质,特别是肌醇(1,4,5)-三磷酸[Ins(1,4,5)P(3)]受体,被证明在GPCR激活后会发生泛素化。受调控的泛素化会导致Ins(1,4,5)P(3)受体的蛋白酶体降解,并且似乎控制着GPCR的内吞作用和运输。确定泛素化在GPCR介导的信号传导中的作用是一项重要任务,因为干扰泛素-蛋白酶体通路的新型药物目前正被批准作为治疗剂。